MoneyWorks4Me

The revenue for the September 2025 quarter is pegged at Rs. 10226.50 millions, about 7.00% up against Rs. 9557.60 millions recorded during the year-ago period.Net profit stood at Rs. 2004.20  millions  compared to Rs. 1731.20 millions in the corresponding previous quarter,high by 15.77%.Operating profit for the quarter ended September 2025 rose to 3126.10 millions as compared to 2770.70 millions of corresponding quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 10226.50 9557.60 7.00 20625.50 19080.70 8.10 37229.20 32986.40 12.86
Other Income 142.50 88.90 60.29 281.50 140.50 100.36 347.40 346.80 0.17
PBIDT 3126.10 2770.70 12.83 6196.30 5556.10 11.52 10526.80 9141.00 15.16
Interest 10.10 20.20 -50.00 16.70 63.40 -73.66 91.20 405.20 -77.49
PBDT 3116.00 2750.50 13.29 6179.60 5492.70 12.51 10435.60 8735.80 19.46
Depreciation 431.10 408.50 5.53 845.10 808.60 4.51 1664.50 1352.40 23.08
PBT 2684.90 2342.00 14.64 5334.50 4684.10 13.89 8771.10 7383.40 18.79
TAX 680.70 610.80 11.44 1351.60 1220.60 10.73 2245.70 1949.80 15.18
Deferred Tax 30.80 90.40 -65.93 69.80 174.10 -59.91 328.80 494.90 -33.56
PAT 2004.20 1731.20 15.77 3982.90 3463.50 15.00 6525.40 5433.60 20.09
Equity 156.60 155.30 0.84 156.60 155.30 0.84 155.70 155.20 0.32
PBIDTM(%) 30.57 28.99 5.45 30.04 29.12 3.17 28.28 27.71 2.04
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..